These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 34644761)

  • 1. [Factors associated with underreporting of cases of multidrug-resistant tuberculosis in the state of Rio de Janeiro, Brazil: probabilistic database linkage].
    Silva MLBD; Durovini P; Mota P; Kritski AL
    Cad Saude Publica; 2021; 37(10):e00293920. PubMed ID: 34644761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors for unfavourable treatment in MDR-TB and XDR-TB patients in Rio de Janeiro State, Brazil, 2000-2016.
    Bhering M; Duarte R; Kritski A
    PLoS One; 2019; 14(11):e0218299. PubMed ID: 31747405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-resistant tuberculosis in six hospitals in Rio de Janeiro, Brazil.
    Brito RC; Mello FC; Andrade MK; Oliveira H; Costa W; Matos HJ; Lourenço MC; Rolla VC; Fonseca L; Ruffino Netto A; Kritski AL
    Int J Tuberc Lung Dis; 2010 Jan; 14(1):24-33. PubMed ID: 20003691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gaps in drug-resistant tuberculosis surveillance: probabilistic database linkage in Brazil].
    Bartholomay P; Pinheiro RS; Johansen FDC; Oliveira SB; Rocha MS; Pelissari DM; Araújo WN
    Cad Saude Publica; 2020; 36(5):e00082219. PubMed ID: 32402004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in primary multidrug-resistant tuberculosis in the State of Rio de Janeiro: a retrospective study conducted during 2000-2019.
    Bhering M; Kritski A
    Rev Soc Bras Med Trop; 2021; 54():e00862021. PubMed ID: 34431941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcomes and predictive factors for multidrug-resistant TB and HIV coinfection in Rio de Janeiro State, Brazil.
    Bhering M; Duarte R; Kritski A
    Int J Tuberc Lung Dis; 2021 Apr; 25(4):292-298. PubMed ID: 33762073
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment outcomes of MDR-tuberculosis patients in Brazil: a retrospective cohort analysis.
    Bastos ML; Cosme LB; Fregona G; do Prado TN; Bertolde AI; Zandonade E; Sanchez MN; Dalcolmo MP; Kritski A; Trajman A; Maciel ELN
    BMC Infect Dis; 2017 Nov; 17(1):718. PubMed ID: 29137626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug-resistant tuberculosis in the Amazonas State, Brazil, 2000-2011.
    Garrido Mda S; Bührer-Sékula S; Souza AB; de Oliveira GP; Antunes IA; Mendes JM; Saraceni V; Martinez-Espinosa FE; Ramasawmy R
    Int J Tuberc Lung Dis; 2015 May; 19(5):531-6. PubMed ID: 25868020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with loss to follow-up and death in cases of drug-resistant tuberculosis (DR-TB) treated at a reference center in Rio de Janeiro, Brazil.
    Viana PVS; Redner P; Ramos JP
    Cad Saude Publica; 2018 May; 34(5):e00048217. PubMed ID: 29768580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterisation of multidrug-resistant Mycobacterium tuberculosis isolates from a high-burden tuberculosis state in Brazil.
    Salvato RS; Schiefelbein S; Barcellos RB; Praetzel BM; Anusca IS; Esteves LS; Halon ML; Unis G; Dias CF; Miranda SS; de Almeida IN; de Assis Figueredo LJ; Silva EC; Kritski AL; Dalla Costa ER; Rossetti MLR
    Epidemiol Infect; 2019 Jan; 147():e216. PubMed ID: 31364547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evolution of a group of patients with multidrug-resistant TB treated at a referral center in the city of Rio de Janeiro, Brazil.
    Siqueira HR; Freitas FA; Oliveira DN; Barreto AM; Dalcolmo MP; Albano RM
    J Bras Pneumol; 2009 Jan; 35(1):54-62. PubMed ID: 19219331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of multidrug-resistant tuberculosis in São Paulo-Brazil: a multilevel Bayesian analysis of factors associated with individual, community and access to health services.
    Arroyo LH; Yamamura M; Ramos ACV; Campoy LT; Crispim JA; Berra TZ; Alves LS; Alves YM; Dos Santos FL; Souza LLL; Bruce ATI; de Andrade HLP; Bollela VR; Krainski ET; Nunes C; Arcêncio RA
    Trop Med Int Health; 2020 Jul; 25(7):839-849. PubMed ID: 32358845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of anti-tuberculosis drug resistance in an HIV/AIDS reference hospital in Rio de Janeiro, Brazil.
    Aguiar F; Vieira MA; Staviack A; Buarque C; Marsico A; Fonseca L; Chaisson R; Kristski A; Werneck G; Mello F
    Int J Tuberc Lung Dis; 2009 Jan; 13(1):54-61. PubMed ID: 19105879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital-based study.
    Sharma SK; George N; Kadhiravan T; Saha PK; Mishra HK; Hanif M
    Indian J Med Res; 2009 Oct; 130(4):392-5. PubMed ID: 19942741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tuberculosis Laboratory Surveillance Network (TuLSA) study group. The first step for national tuberculosis laboratory surveillance: Ankara, 2011].
    Sezen F; Albayrak N; Özkara Ş; Karagöz A; Alp A; Duyar Ağca F; İnan Süer A; Müderris T; Ceyhan İ; Durmaz R; Ertek M;
    Mikrobiyol Bul; 2015 Apr; 49(2):143-55. PubMed ID: 26167815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic diversity of Mycobacterium tuberculosis isoniazid monoresistant and multidrug-resistant in Rio Grande do Sul, a tuberculosis high-burden state in Brazil.
    Esteves LS; Dalla Costa ER; Vasconcellos SEG; Vargas A; Ferreira Junior SLM; Halon ML; Ribeiro MO; Rodenbusch R; Gomes HM; Suffys PN; Rossetti MLR
    Tuberculosis (Edinb); 2018 May; 110():36-43. PubMed ID: 29779771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of time to unfavorable treatment outcomes among patients with multidrug resistant tuberculosis in Oromia region, Ethiopia.
    Woldeyohannes D; Assefa T; Aman R; Tekalegn Y; Hailemariam Z
    PLoS One; 2019; 14(10):e0224025. PubMed ID: 31665154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug-resistant TB in Zambia: review of national data from 2000 to 2011.
    Kapata N; Chanda-Kapata P; Bates M; Mwaba P; Cobelens F; Grobusch MP; Zumla A
    Trop Med Int Health; 2013 Nov; 18(11):1386-91. PubMed ID: 24033538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of childhood multi-drug resistant tuberculosis in Johannesburg, South Africa: a cross sectional study.
    Fairlie L; Beylis NC; Reubenson G; Moore DP; Madhi SA
    BMC Infect Dis; 2011 Jan; 11():28. PubMed ID: 21269475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary drug resistance among pulmonary treatment-naïve tuberculosis patients in Amazonas State, Brazil.
    da Silva Garrido M; Ramasawmy R; Perez-Porcuna TM; Zaranza E; Chrusciak Talhari A; Martinez-Espinosa FE; Bührer-Sékula S
    Int J Tuberc Lung Dis; 2014 May; 18(5):559-63. PubMed ID: 24903793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.